Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2016 - Issue
Submit an article Journal homepage
202
Views
117
CrossRef citations to date
0
Altmetric
Original Research

Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD

Netsanet A Negewo1 Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;2 Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, AustraliaCorrespondence[email protected]
,
Vanessa M McDonald1 Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;2 Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;3 Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia;4 School of Nursing and Midwifery, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia
,
Katherine J Baines1 Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;2 Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia
,
Peter AB Wark1 Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;2 Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;3 Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia
,
Jodie L Simpson1 Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;2 Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia
,
Paul W Jones5 Institute for Infection and Immunity, St George’s, University of London, London, UK
&
Peter G Gibson1 Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;2 Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia;3 Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia
 show all
Pages 1495-1504 | Published online: 01 Jul 2016

Citations (117)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (33)

Ambedkar Kumar Yadav, Wenhua Gu, Tongyangzi Zhang, Xianghuai Xu & Li Yu. (2023) Current Perspectives on Biological Therapy for COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 20:1, pages 197-209.
Read now
Laura Millares & Eduard Monso. (2022) The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1835-1845.
Read now
Takako Tanaka, Minoru Okita, Sue Jenkins & Ryo Kozu. (2022) Clinical and Psychological Impact of Chronic Pain in People with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 893-903.
Read now
Calvin You Jia Chen, Min Sen Yew, John Arputhan Abisheganaden & Huiying Xu. (2022) Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 25-32.
Read now
Anastasia Papaporfyriou, Petros Bakakos, Georgios Hillas, Andriana I. Papaioannou & Stelios Loukides. (2022) Blood eosinophils in COPD: friend or foe?. Expert Review of Respiratory Medicine 16:1, pages 35-41.
Read now
Natasha A Winter, Peter G Gibson, Vanessa M McDonald & Michael Fricker. (2021) Sputum Gene Expression Reveals Dysregulation of Mast Cells and Basophils in Eosinophilic COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2165-2179.
Read now
Natalia Celejewska-Wójcik, Aleksander Kania, Karolina Górka, Paweł Nastałek, Krzysztof Wójcik, Anna Gielicz, Lucyna Mastalerz, Marek Sanak & Krzysztof Sładek. (2021) Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1415-1424.
Read now
Ian D Pavord, Kenneth R Chapman, Mona Bafadhel, Frank C Sciurba, Eric S Bradford, Stephanie Schweiker Harris, Bhabita Mayer, David B Rubin, Steven W Yancey & Pierluigi Paggiaro. (2021) Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1755-1770.
Read now
Konstantinos Kostikas, Evgenia Papathanasiou, Andriana I. Papaioannou, Konstantinos Bartziokas, Ilias C. Papanikolaou, Emmanouil Antonakis, Ioanna Makou, Georgios Hillas, Τheodoros Karampitsakos, Ourania Papaioannou, Katerina Dimakou, Vicky Apollonatou, Galateia Verykokou, Spyros Papiris, Petros Bakakos & Stelios Loukides. (2021) Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study. Biomarkers 26:4, pages 354-362.
Read now
Ronald F. Grossman. (2021) Blood eosinophils in COPD to predict exacerbations and inform inhaled corticosteroid use: Need for further evidence?. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 5:3, pages 136-149.
Read now
Peter J. Barnes. (2021) Endo-phenotyping of COPD patients. Expert Review of Respiratory Medicine 15:1, pages 27-37.
Read now
Andriana I Papaioannou, Stelios Loukides, Petros Bakakos, Epameinondas N Kosmas, Nikoletta Rovina, Paschalis Steiropoulos, Evangellia Fouka, Georgios Hillas, Georgios Patentalakis, Marousa Kouvela & Nikos Tzanakis. (2020) Dual Bronchodilator in the Era of Triple Therapy. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2695-2705.
Read now
Balazs Antus, Csilla Paska & Imre Barta. (2020) Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2025-2035.
Read now
Matthew J Hegewald, Benjamin D Horne, Frank Trudo, James L Kreindler, Yen Chung, Susan Rea & Denitza P Blagev. (2020) Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2629-2641.
Read now
Katherine J Baines, Netsanet A Negewo, Peter G Gibson, Juan-Juan Fu, Jodie L Simpson, Peter A B Wark, Michael Fricker & Vanessa M McDonald. (2020) A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1577-1590.
Read now
Ying Zhang, Li-Rong Liang, Shu Zhang, Yong Lu, Yang-Yu Chen, Huan-Zhong Shi & Ying-Xiang Lin. (2020) Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1123-1134.
Read now
Claudio Tantucci & Laura Pini. (2020) Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 821-829.
Read now
Xiaoqian Liu, Hong Zhang, Ying Wang, Yue Lu, Yanli Gao, Yong Lu, Chunming Zheng, Danfeng Yin, Shurui Wang & Kewu Huang. (2020) Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:2, pages 121-127.
Read now
G. Hillas, A. Papaporfyriou, K. Dimakou & A. I. Papaioannou. (2020) Pharmacological treatment of stable COPD: need for a simplified approach. Postgraduate Medicine 132:2, pages 126-131.
Read now
Ajmal Jabarkhil, Mia Moberg, Julie Janner, Mie Nymann Petersen, Camilla Bjørn Jensen, Lars Henrik Ängquist, Jørgen Vestbo, Tine Jess & Celeste Porsbjerg. (2020) Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis. European Clinical Respiratory Journal 7:1.
Read now
Malgorzata Proboszcz, Katarzyna Mycroft, Magdalena Paplinska-Goryca, Katarzyna Górska, Patrycja Nejman-Gryz, Piotr Jankowski, Natalia Zak & Rafal Krenke. (2019) Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:5-6, pages 354-361.
Read now
Juwhan Choi, Jee Youn Oh, Young Seok Lee, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Kyung Ho Kang & Kyung Hoon Min. (2019) The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 953-959.
Read now
Job J. M. H. van Bragt, Susanne J. H. Vijverberg, Els J. M. Weersink, Levi B. Richards, Anne H. Neerincx, Peter J. Sterk, Elisabeth H. D. Bel & Anke H. Maitland-van der Zee. (2018) Blood biomarkers in chronic airways diseases and their role in diagnosis and management. Expert Review of Respiratory Medicine 12:5, pages 361-374.
Read now
Ioanna Tsiligianni & Alan G Kaplan. (2018) Are blood eosinophils a prime-time biomarker for COPD management decisions?. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1889-1891.
Read now
Luis Pérez de Llano, Borja G Cosío, Amanda Iglesias, Natividad de las Cuevas, Juan Jose Soler-Cataluña, Jose Luis Izquierdo, Jose Luis López-Campos, Carmen Calero, Vicente Plaza, Marc Miravitlles, Alfons Torrego, Eva Martinez-Moragon, Joan B Soriano, Antolin Lopez Viña & Irina Bobolea. (2018) Mixed Th2 and non-Th2 inflammatory pattern in the asthma–COPD overlap: a network approach. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 591-601.
Read now
Donald P Tashkin & Michael E Wechsler. (2018) Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 335-349.
Read now
Matevz Harlander, Miriam Barrecheguren, Matjaz Turel & Marc Miravitlles. (2017) Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 465-468.
Read now
Jie Gao, Wutie Zhou, Bida Chen, Weiming Lin, Sifang Wu & Feng Wu. (2017) Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2703-2710.
Read now
Shih-Lung Cheng, Hsu Hui Wang & Ching-Hsiung Lin. (2017) Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2231-2238.
Read now
Jie Gao, Min Zhang, Liqin Zhou, Xing Yang, Haigui Wu, Jianfang Zhang & Feng Wu. (2017) Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1287-1293.
Read now
Kirill A Zykov & Svetlana I Ovcharenko. (2017) Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1125-1133.
Read now
Terence Ho, Angira Dasgupta, Frederick E. Hargreave & Parameswaran Nair. (2017) The use of cellular and molecular biomarkers to manage COPD exacerbations. Expert Review of Respiratory Medicine 11:5, pages 403-411.
Read now
Paola Rogliani, Josuel Ora, Ermanno Puxeddu & Mario Cazzola. (2016) Airflow obstruction: is it asthma or is it COPD?. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3007-3013.
Read now

Articles from other publishers (84)

Alexander Jordan, Pradeesh Sivapalan, Valdemar Rømer & Jens-Ulrik Jensen. (2023) Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method. Biomedicines 11:5, pages 1395.
Crossref
Larry Borish, W. Gerald Teague, James T. Patrie, Kristin W. Wavell, Andrew J. Barros, H. Charles Malpass & Monica G. Lawrence. (2023) Further evidence of a type 2 inflammatory signature in chronic obstructive pulmonary disease or emphysema. Annals of Allergy, Asthma & Immunology 130:5, pages 617-621.e1.
Crossref
Li-Li Shui, Ji-Jun Cai, Xiao-Qing Zhong, You-Lun Li, Mao-Rui He & Ya-Juan Chen. (2023) Chronic Obstructive Pulmonary Disease Patients With High Peripheral Blood Eosinophil Counts Have Better Predicted Improvement in 6MWD After Rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention 43:2, pages 122-128.
Crossref
Tsunahiko Hirano & Kazuto Matsunaga. (2023) Measurement of Blood Eosinophils in Asthma and Chronic Obstructive Pulmonary Disease. Internal Medicine 62:1, pages 21-25.
Crossref
Si Cong Ye, Sameer Desai, Emma Karlsen, Eugenie Kwong, Pearce G. Wilcox & Bradley S. Quon. (2022) Association between elevated peripheral blood eosinophil count and respiratory outcomes in adults with cystic fibrosis. Journal of Cystic Fibrosis 21:6, pages 1048-1052.
Crossref
Rodrigo Núñez-Cortés, Paloma Padilla-Acevedo, Franchesca Vergara-Peña, Sara Mollà-Casanova, Claudia Espinoza-Bravo, Rodrigo Torres-Castro & Carlos Cruz-Montecinos. (2022) Clinical assessment of balance and functional impairments in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. ERJ Open Research 8:4, pages 00164-2022.
Crossref
Huan Minh Tran, Tzu-Tao Chen, Yueh-Hsun Lu, Feng-Jen Tsai, Kuan-Yuan Chen, Shu-Chuan Ho, Chih-Da Wu, Sheng-Ming Wu, Yueh-Lun Lee, Kian Fan Chung, Han-Pin Kuo, Kang-Yun Lee & Hsiao-Chi Chuang. (2022) Climate-mediated air pollution associated with COPD severity. Science of The Total Environment 843, pages 156969.
Crossref
M. Gueçamburu & M. Zysman. (2022) BPCO et éosinophiles. Revue des Maladies Respiratoires 39:8, pages 685-697.
Crossref
Parvarish Sharma, Daljeet Singh Dhanjal, Chirag Chopra, Murtaza M. Tambuwala, Sukhwinder Singh Sohal, Peter J. van der Spek, Hari S. Sharma & Saurabh Satija. (2022) Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery. Chemico-Biological Interactions 365, pages 110050.
Crossref
Balazs Antus & Imre Barta. (2022) Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation. Biomedicines 10:9, pages 2128.
Crossref
Pelin Uysal. 2022. Biomarkers in Medicine. Biomarkers in Medicine 425 439 .
Sachin Singh, Prawin Kumar, Jagdish Prasad Goyal & Kuldeep Singh. (2022) Relationship of Peripheral Blood Counts with Asthma Control. Indian Journal of Pediatrics.
Crossref
Dave Singh, Alvar AgustiFernando J. MartinezAlberto Papi, Ian D. PavordJadwiga A. WedzichaClaus F. Vogelmeier & David M. G. Halpin. (2022) Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. American Journal of Respiratory and Critical Care Medicine 206:1, pages 17-24.
Crossref
Sabine Farschtschi, Martin Mattes & Michael W. Pfaffl. (2022) Advantages and Challenges of Differential Immune Cell Count Determination in Blood and Milk for Monitoring the Health and Well-Being of Dairy Cows. Veterinary Sciences 9:6, pages 255.
Crossref
Aleksandar Dobric, Simone N. De Luca, Sarah J. Spencer, Steven Bozinovski, Michael M. Saling, Christine F. McDonald & Ross Vlahos. (2022) Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease. Pharmacology & Therapeutics 233, pages 108017.
Crossref
Ioannis Pantazopoulos, Kalliopi Magounaki, Ourania Kotsiou, Erasmia Rouka, Fotis Perlikos, Sotirios Kakavas & Konstantinos Gourgoulianis. (2022) Incorporating Biomarkers in COPD Management: The Research Keeps Going. Journal of Personalized Medicine 12:3, pages 379.
Crossref
B. Çekmen, B. Bildik, Atiş Ş. Emre, N. Kaya, Ö. Bozan & A. Kalkan. (2022) Eosinophil count can predict dyspnea level in patients with acute exacerbation of chronic obstructive pulmonary disease. PULMONOLOGIYA 32:1, pages 62-67.
Crossref
Meropi Karakioulaki & Daiana Stolz. 2022. Eosinophilic Lung Diseases. Eosinophilic Lung Diseases 100 118 .
Nilüfer Aylin Acet‐Öztürk, Asli G. Dilektasli, Özge Aydın‐Güçlü, Ezgi Demirdöğen, Funda Coşkun, Ahmet Ursavaş, Mehmet Karadağ & Esra Uzaslan. (2021) Long‐term oxygen treatment need is less frequent in eosinophilic COPD patients. The Clinical Respiratory Journal 16:1, pages 49-56.
Crossref
Sarah Clarke & Peter Barnes. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 549 558 .
Hye Seon Kang, Sung Kyoung Kim, Yong Hyun Kim, Jin Woo Kim, Sang Haak Lee, Hyung Kyu Yoon & Chin Kook Rhee. (2021) The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. BMC Pulmonary Medicine 21:1.
Crossref
Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, Alberto Papi, Aida Emirova & Mirco Govoni. (2021) Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology 12.
Crossref
Andrew Li, Hiang Ping Chan, Phyllis X.L. Gan, Mei Fong Liew, W.S. Fred Wong & Hui-Fang Lim. (2021) Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma. The Korean Journal of Internal Medicine 36:6, pages 1305-1319.
Crossref
Hye Yun Park, Yoosoo Chang, Danbee Kang, Yun Soo Hong, Di Zhao, Jiin Ahn, Sun Hye Shin, Dave Singh, Eliseo Guallar, Juhee Cho & Seungho Ryu. (2021) Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study. European Respiratory Journal 58:4, pages 2003823.
Crossref
Howraman Meteran, Pradeesh Sivapalan & Jens-Ulrik Stæhr Jensen. (2021) Treatment Response Biomarkers in Asthma and COPD. Diagnostics 11:9, pages 1668.
Crossref
Elie J. Mitri, David X. Zheng, Vebhav Garg, Cassandra C. Crifase, Nicole M. Herrera, Janice A. Espinola, Kohei Hasegawa & Carlos A. CamargoJr.,Jr.,. (2021) Blood eosinophils, specific immunoglobulin E, and bronchiolitis severity. Pediatric Pulmonology 56:9, pages 2997-3004.
Crossref
Sumitra Shantakumar, Yu-Fan Ho, Janine Beale & Barry Gribben. (2021) Burden of illness in blood eosinophilic phenotype COPD patients in New Zealand. Respiratory Investigation 59:4, pages 487-497.
Crossref
Peter M. A. Calverley & Paul Phillip Walker. (2021) ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against. Diagnostics 11:7, pages 1189.
Crossref
Alfian Nurfaizi, Isnin Anang Marhana, Gadis Meinar Sari & Arief Bakhtiar. (2021) Correlation between FEV1% Predicted and Blood Eosinophils in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Jurnal Respirasi 7:2, pages 59.
Crossref
Pradeesh Sivapalan, András Bikov & Jens-Ulrik Jensen. (2021) Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease. Diagnostics 11:2, pages 236.
Crossref
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singh, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan & Kamal Dua. (2021) Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sciences 267, pages 118973.
Crossref
Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2021) Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence?. US Respiratory & Pulmonary Diseases 6:1, pages 31.
Crossref
José-Luis Lopez-Campos, Borja Ruiz-Duque, Laura Carrasco-Hernandez & Candelaria Caballero-Eraso. (2021) Einbeziehung von Komorbiditäten und phänotypbasierter Medizin beim patientenzentrierten COPD-Management. Kompass Pneumologie 9:2, pages 60-67.
Crossref
Yajie You & Guo chao Shi. (2021) Blood Eosinophils and Clinical Outcome of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Respiration 100:3, pages 228-237.
Crossref
Sarah A. Hiles, Peter G. Gibson & Vanessa M. McDonald. (2020) Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma–COPD overlap . Respirology 26:1, pages 52-61.
Crossref
Marc Miravitlles, Mònica Monteagudo, Iryna Solntseva & Bernardino Alcázar. (2021) Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study. Archivos de Bronconeumología 57:1, pages 13-20.
Crossref
Marc Miravitlles, Mònica Monteagudo, Iryna Solntseva & Bernardino Alcázar. (2021) Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study. Archivos de Bronconeumología (English Edition) 57:1, pages 13-20.
Crossref
Jose Carlos Herrera Garcia. 2020. Update in Respiratory Diseases. Update in Respiratory Diseases.
Jie Gao, Bida Chen, Sifang Wu & Feng Wu. (2020) Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations. BMC Pulmonary Medicine 20:1.
Crossref
Hiroki Tashiro, Yuki Kurihara, Koichiro Takahashi, Hironori Sadamatsu, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura & Naoko Sueoka-Aragane. (2020) Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease. BMC Pulmonary Medicine 20:1.
Crossref
Zenya Saito, Masahiro Yoshida, Ayako Kojima, Kentaro Tamura, Tsukasa Hasegawa & Kazuyoshi Kuwano. (2020) Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts. Lung 198:6, pages 925-931.
Crossref
Dave Singh, Mona Bafadhel, Christopher E. Brightling, Frank C. Sciurba, Jeffrey L. Curtis, Fernando J. Martinez, Cara B. Pasquale, Debora D. Merrill, Norbert Metzdorf, Stefano Petruzzelli, Ruth Tal-Singer, Christopher Compton, Stephen Rennard & Ubaldo J. Martin. (2020) Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 202:5, pages 660-671.
Crossref
Katarzyna Mycroft, Rafal Krenke & Katarzyna Górska. (2020) Eosinophils in COPD—Current Concepts and Clinical Implications. The Journal of Allergy and Clinical Immunology: In Practice 8:8, pages 2565-2574.
Crossref
José Luis Lopez-Campos, Borja Ruiz-Duque, Laura Carrasco-Hernandez & Candelaria Caballero-Eraso. (2020) Integrating Comorbidities and Phenotype-Based Medicine in Patient-Centered Medicine in COPD. Journal of Clinical Medicine 9:9, pages 2745.
Crossref
Dave Singh, Henrik Watz, Kai Michael Beeh, Oliver Kornmann, Brian Leaker, Brendan Colgan, Germano Lucci, Aida Emirova, Marie Anna Nandeuil, Debora Santoro, Deborah Balzano & Mirco Govoni. (2020) COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition. European Respiratory Journal 56:2, pages 2000237.
Crossref
Dave Singh. (2020) Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects. Tuberculosis and Respiratory Diseases 83:3, pages 185-194.
Crossref
Víctor José Asensio, Anna Tomás, Amanda Iglesias, Luis Pérez de Llano, Victoria del Pozo & Borja G. Cosío. (2020) Eosinophilic COPD Patients Display a Distinctive Serum miRNA Profile From Asthma and Non-eosinophilic COPD. Archivos de Bronconeumología 56:4, pages 234-241.
Crossref
Víctor José Asensio, Anna Tomás, Amanda Iglesias, Luis Pérez de Llano, Victoria del Pozo & Borja G. Cosío. (2020) Eosinophilic COPD Patients Display a Distinctive Serum miRNA Profile From Asthma and Non-eosinophilic COPD. Archivos de Bronconeumología (English Edition) 56:4, pages 234-241.
Crossref
Gerard J Criner, Bartolome R Celli, Dave Singh, Alvar Agusti, Alberto Papi, Maria Jison, Natalya Makulova, Vivian H Shih, Laura Brooks, Peter Barker, Ubaldo J Martin & Paul Newbold. (2020) Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies. The Lancet Respiratory Medicine 8:2, pages 158-170.
Crossref
Yong Suk Jo, Junsu Choe, Sun Hye ShinHyeon-Kyoung KooWon-Yeon LeeYu Il KimSeung Won RaKwang Ha YooKi Suck JungHye Yun Park & Yong-Bum Park. (2020) Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids. Tuberculosis and Respiratory Diseases 83:1, pages 42.
Crossref
Brian Oliver, Katrina Tonga, David Darley, Sandra Rutting, Xin Zhang, Hui Chen & Gang Wang. (2019) COPD treatment choices based on blood eosinophils: are we there yet?. Breathe 15:4, pages 318-323.
Crossref
Francisco‐Javier Gonzalez‐Barcala, Maria‐Esther San‐Jose, Juan‐José Nieto‐Fontarigo, Uxio Calvo‐Alvarez, Jose‐Martín Carreira, Maria‐Teresa Garcia‐Sanz, Xavier Muñoz, Maria-Purificacion Perez‐Lopez‐Corona, Maria-Jose Gómez‐Conde, Alejandro Casas‐Fernández, Luis Valdes‐Cuadrado, Lara Mateo‐Mosquera & Francisco‐Javier Salgado. (2019) Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations. International Journal of Clinical Practice 73:12.
Crossref
S N Avdeev, N V Trushenko, Z M Merzhoeva, M S Ivanova & E V Kusraeva. (2019) Eosinophilic inflammation in chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:10, pages 144-152.
Crossref
Cheng-Sen Cai & Jun Wang. (2019) Blood eosinophil level to predict chronic obstructive pulmonary disease clinical outcomes. Chinese Medical Journal 132:19, pages 2373-2375.
Crossref
Andrius Januskevicius, Ieva Janulaityte, Virginija Kalinauskaite-Zukauske, Reinoud Gosens & Kestutis Malakauskas. (2019) The Enhanced Adhesion of Eosinophils Is Associated with Their Prolonged Viability and Pro-Proliferative Effect in Asthma. Journal of Clinical Medicine 8:9, pages 1274.
Crossref
Martin Ian MacDonald, Christian R. Osadnik, Lauren Bulfin, Kais Hamza, Paul Leong, Anders Wong, Paul T. King & Philip G. Bardin. (2019) Low and High Blood Eosinophil Counts as Biomarkers in Hospitalized Acute Exacerbations of COPD. Chest 156:1, pages 92-100.
Crossref
Peter J. Barnes. (2019) Inflammatory endotypes in COPD. Allergy.
Crossref
Umesh Singh, Victoria Wangia-Anderson & Jonathan A. Bernstein. (2019) Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease. The Journal of Allergy and Clinical Immunology: In Practice 7:1, pages 279-285.e6.
Crossref
Sun Hye Shin, Hye Yun Park, Danbee Kang, Juhee Cho, Sung Ok Kwon, Joo Hun Park, Jae Seung Lee, Yeon-Mok Oh, Don D. Sin, Woo Jin Kim & Sang-Do Lee. (2018) Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease. Respiratory Research 19:1.
Crossref
Floor J. Hartjes, Judith M. Vonk, Alen Faiz, Pieter S. Hiemstra, Thérèse S. Lapperre, Huib A.M. Kerstjens, Dirkje S. Postma & Maarten van den Berge. (2018) Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD. Respirology 23:11, pages 1023-1031.
Crossref
Venkataramana K. Sidhaye, Kristine Nishida & Fernando J. Martinez. (2018) Precision medicine in COPD: where are we and where do we need to go?. European Respiratory Review 27:149, pages 180022.
Crossref
Wei-Chang Huang, Ching-Hsiao Lee, Ming-Feng Wu, Chen-Cheng Huang, Cheng-Hui Hsu, Hui-Chen Chen, Jeng-Yuan Hsu & Chieh-Chen Huang. (2018) Clinical features, bacteriology of endotracheal aspirates and treatment outcomes of patients with chronic obstructive pulmonary disease and community-acquired pneumonia in an intensive care unit in Taiwan with an emphasis on eosinophilia versus non-eosinophilia: a retrospective case–control study. BMJ Open 8:9, pages e020341.
Crossref
Jose Luis Lopez-Campos, Laura Carrasco Hernández, Xavier Muñoz, Víctor Bustamante & Esther Barreiro. (2018) Current controversies in the stepping up and stepping down of inhaled therapies for COPD at the patient level. Respirology 23:9, pages 818-827.
Crossref
Pedro J Marcos & José Luis López-Campos. (2018) Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)? CON. Medical Sciences 6:2, pages 49.
Crossref
Signe Vedel-Krogh, Børge G. Nordestgaard, Peter Lange, Jørgen Vestbo & Sune F. Nielsen. (2018) Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD. European Respiratory Journal 51:5, pages 1800120.
Crossref
Guy Brusselle, Ian D. Pavord, Sarah Landis, Steven Pascoe, Sally Lettis, Nikhil Morjaria, Neil Barnes & Emma Hilton. (2018) Blood eosinophil levels as a biomarker in COPD. Respiratory Medicine 138, pages 21-31.
Crossref
Robert S. Zeiger, Trung N. Tran, Rebecca K. Butler, Michael Schatz, Qiaowu Li, Deepak B. Khatry, Ubaldo Martin, Aniket A. Kawatkar & Wansu Chen. (2018) Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease. The Journal of Allergy and Clinical Immunology: In Practice 6:3, pages 944-954.e5.
Crossref
Ian D. Pavord. (2018) COUNTERPOINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? No. Chest 153:4, pages 782-784.
Crossref
Luis Pérez de Llano, Borja G. Cosío, Marc Miravitlles & Vicente Plaza. (2018) Accuracy of a New Algorithm to Identify Asthma–COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease. Archivos de Bronconeumología 54:4, pages 198-204.
Crossref
Luis Pérez de Llano, Borja G. Cosío, Marc Miravitlles & Vicente Plaza. (2018) Accuracy of a New Algorithm to Identify Asthma–COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease. Archivos de Bronconeumología (English Edition) 54:4, pages 198-204.
Crossref
Paul Morgan, Dean G. Brown, Simon Lennard, Mark J. Anderton, J. Carl Barrett, Ulf Eriksson, Mark Fidock, Bengt Hamrén, Anthony Johnson, Ruth E. March, James Matcham, Jerome Mettetal, David J. Nicholls, Stefan Platz, Steve Rees, Michael A. Snowden & Menelas N. Pangalos. (2018) Impact of a five-dimensional framework on R&D productivity at AstraZeneca. Nature Reviews Drug Discovery 17:3, pages 167-181.
Crossref
. (2018) Mepolizumab for Eosinophilic COPD. New England Journal of Medicine 378:7, pages 680-683.
Crossref
Nicolas Roche, Maeva Zysman & Pierre-Régis Burgel. (2018) Blood eosinophil counts as a guide for COPD treatment strategies. The Lancet Respiratory Medicine 6:2, pages 78-80.
Crossref
Peter G. Gibson. (2018) Variability of blood eosinophils as a biomarker in asthma and COPD. Respirology 23:1, pages 12-13.
Crossref
Umme Kolsum, Gavin C. Donaldson, Richa Singh, Bethan L. Barker, Vandana Gupta, Leena George, Adam J. Webb, Sarah Thurston, Anthony J Brookes, Timothy D. McHugh, Jadwiga A. Wedzicha, Christopher E. Brightling & Dave Singh. (2017) Blood and sputum eosinophils in COPD; relationship with bacterial load. Respiratory Research 18:1.
Crossref
Annette T Hastie, Fernando J Martinez, Jeffrey L Curtis, Claire M Doerschuk, Nadia N Hansel, Stephanie Christenson, Nirupama Putcha, Victor E Ortega, Xingnan Li, R Graham Barr, Elizabeth E Carretta, David J Couper, Christopher B Cooper, Eric A Hoffman, Richard E Kanner, Eric Kleerup, Wanda K O'Neal, Richard PaineIIIIII, Stephen P Peters, Neil E Alexis, Prescott G Woodruff, MeiLan K Han, Deborah A Meyers, Eugene R Bleecker, Neil E Alexis, Wayne H Anderson, R Graham Barr, Eugene R Bleecker, Richard C Boucher, Russell P Bowler, Elizabeth E Carretta, Stephanie A Christenson, Alejandro P Comellas, Christopher B Cooper, David J Couper, Gerard J Criner, Ronald G Crystal, Jeffrey L Curtis, Claire M Doerschuk, Mark T Dransfield, Christine M Freeman, MeiLan K Han, Nadia N Hansel, Annette T Hastie, Eric A Hoffman, Robert J Kaner, Richard E Kanner, Eric C Kleerup, Jerry A Krishnan, Lisa M LaVange, Stephen C Lazarus, Fernando J Martinez, Deborah A Meyers, John D NewellJrJr, Elizabeth C Oelsner, Wanda K O'Neal, Robert PaineIIIIII, Nirupama Putcha, Stephen I. Rennard, Donald P Tashkin, Mary Beth Scholand, J Michael Wells, Robert A Wise & Prescott G Woodruff. (2017) Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. The Lancet Respiratory Medicine 5:12, pages 956-967.
Crossref
Ciro Casanova, Bartolome R. Celli, Juan P. de-Torres, Cristina Martínez-Gonzalez, Borja G. Cosio, Victor Pinto-Plata, Pilar de Lucas-Ramos, Miguel Divo, Antonia Fuster, Germán Peces-Barba, Myriam Calle-Rubio, Ingrid Solanes, Ramón Aguero, Nuria Feu-Collado, Inmaculada Alfageme, Alfredo De Diego, Amparo Romero, Eva Balcells, Antonia Llunell, Juan B. Galdiz, Margarita Marin, Amalia Moreno, Carlos Cabrera, Rafael Golpe, Celia Lacarcel, Joan B. Soriano, José Luis López-Campos, Juan J. Soler-Cataluña & José M. Marin. (2017) Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD. European Respiratory Journal 50:5, pages 1701162.
Crossref
Jeffery Ho, Wajia He, Matthew T. V. Chan, Gary Tse, Tong Liu, Sunny H. Wong, Czarina C. H. Leung, Wai T. Wong, Sharon Tsang, Lin Zhang, Rose Y. P Chan, Tony Gin, Joseph Leung, Benson W. M. Lau, William K. K. Wu & Shirley P. C. Ngai. (2017) Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis. Scientific Reports 7:1.
Crossref
Vanessa L. Clark, Peter G. Gibson, Grayson Genn, Sarah A. Hiles, Ian D. Pavord & Vanessa M. McDonald. (2017) Multidimensional assessment of severe asthma: A systematic review and meta-analysis. Respirology 22:7, pages 1262-1275.
Crossref
Bartolome Celli. (2017) Is the Blood Eosinophil Count a Useful Biomarker in COPD? The devil is in the Details!. Archivos de Bronconeumología 53:8, pages 415-416.
Crossref
Bartolome Celli. (2017) Is the Blood Eosinophil Count a Useful Biomarker in COPD? The devil is in the Details!. Archivos de Bronconeumología (English Edition) 53:8, pages 415-416.
Crossref
Borja G. Cosío, Luis Pérez de Llano, Antolin Lopez Viña, Alfons Torrego, Jose Luis Lopez-Campos, Joan B. Soriano, Eva Martinez Moragon, Jose Luis Izquierdo, Irina Bobolea, Javier Callejas, Vicente Plaza, Marc Miravitlles & Juan Jose Soler-Catalunya. (2017) Th-2 signature in chronic airway diseases: towards the extinction of asthma−COPD overlap syndrome?. European Respiratory Journal 49:5, pages 1602397.
Crossref
A. Wäsche. (2017) Kommentar zur Post-hoc-Analyse der WISDOM-Studie zur COPD mit EosinophilieComments on the post hoc analysis of the WISDOM trial on COPD with eosinophilia. Der Pneumologe 14:3, pages 170-173.
Crossref
Diahn-Warng PerngPei-Ku Chen. (2017) The Relationship between Airway Inflammation and Exacerbation in Chronic Obstructive Pulmonary Disease. Tuberculosis and Respiratory Diseases 80:4, pages 325.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.